Evaluation of the BMI in Patients Undergoing Cholecystectomy in the Hospitals of Babol Medical University in the Years 2014-2016

Document Type : Original Article

Authors

1 Assistant Professor, Department of General Surgery, Babol University of Medical Sciences, Shahid Beheshti Hospital, Babol

2 Associate Professor, Department of Thoracic Surgery, Babol University of Medical Sciences, Shahid Beheshti Hospital, Babol

3 Expert, Clinical Research Development Unit, Babol University of Medical Sciences, Shahid Beheshti Hospital, Babol

4 General Practitioner, Babol University of Medical Sciences, Babol, Iran

Abstract
Introduction & Objective: Gallstones and its complications are the most gastrointestinal diseases that in most cases, it resulted in hospitalization and cholecystectomy. The aim of present study was to assess body mass index in patients with Gallstones and its complications that underwent cholecystectomy. Materials & Methods: 351 patients who were undergone cholecystectomy due to Gallstones and its complications were included in the present cross-sectional study. 201 patients (57.3%) who referred for biliary causes to surgery clinic were included in the control group and 150 patients (42.7%) were allocated to the case group. Results: Chronic cholecystitis with 110 cases (73.3%) accounted for the majority. About the variable body mass index, 9 patients of the case group (6%) and 15 patients of the control group (7.5%) had a body mass index greater than 30 kg per square meter (morbid obesity), but the association was not statistically significant (P=0.784). After examining LDL and HDL, there was no significant difference in LDL/HDL ratio with type of disease of case group. Conclusions: The results of present study showed that the prevalence of gallstones in patients with normal BMI was more than individuals with overweight and fat. In this geographical area, the prevalence of gallstones are depending on other factors such as pregnancies, the underlying chronic disease and blood diseases.

Keywords


1. Braunwald E, Fauci A, Kasper D, editors. Harrison s textbook of international medicine. 10ed ed2015.
2. Faghihi Kashani AH, Bitarafan S, Zangeneh Kazemi A, Kabir A. The Relationship between Gallstone Formation and Diabetes Mellitus. University of Medical Sciences Iran. 2004; 11(42): 597-604.
3. Hou L, Ji BT, Blair A, Dai Q, Gao YT, Chow WH. Commuting physical activity and risk of colon cancer in Shanghai, China. Am J Epidemiol. 2004; 160(9): 860-7.
4. Wei J, Chang CY, Chuang YC, Young MS, Huang CM, Yin WH, et al. Heart transplantation at Cheng Hsin General Hospital in Taiwan: 15-year experience. Transplant Proc. 2004; 36(8): 2374-6.
5. Massarrat S. Prevalence of gallstone disease in Iran. Journal of gastroenterology and hepatology. 2001; 16(5): 564-7.
6. Moazeni-Bistgani M, Mohammad Ali-Beigi F, Shahrjerdi S. Assessment of oral acetazolamide on postoperative pain after laparoscopic cholecystectomy. Journal of Shahrekord University of medical sciences. 2010; 12(2): 21-7.
7. Hunter J, Oddsdottir M, editors. Gallbladder and the extra hepatic billiary system. Schwartz’s principles of surgery. 10th ed. NewYork: McGraw Hill Company 2015.
8. Novacek G. Gender and gallstone disease. Wien Med Wochenschr. 2006; 156(19-20): 527-33.
9. Radmard AR, Merat S, Kooraki S, Ashraf M, Keshtkar A, Sharafkhah M, et al. Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences. Ann Hepatol. 2015; 14(5): 702-9.
10.    Sun H, Tang H, Jiang S, Zeng L, Chen EQ, Zhou TY, et al. Gender and metabolic differences of gallstone diseases. World J Gastroenterol. 2009; 15(15): 1886-91.
11.    Bonfrate L, Wang DQH, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Practice & Research Clinical Gastroenterology. 2014; 28(4): 623-35.
12.    Wakasugi M, Tanemura M, Tei M, Furukawa K, Suzuki Y, Masuzawa T, et al. Safety and feasibility of single-incision laparoscopic cholecystectomy in obese patients. Annals of Medicine and Surgery. 2017; 13: 34-7.
13.    Cruz-Monserrate Z, Conwell DL, Krishna SG. The Impact of Obesity on Gallstone Disease, Acute Pancreatitis, and Pancreatic Cancer. Gastroenterology Clinics of North America. 2016; 45(4): 625-37.
14.    Jianjuni Y, Qian Z, Jun S, Feiguo Z, Liang H, Caifeng L, et al. Chronic acalculous cholecystitis: correlation of clinical assessment, laboratory data and final histopathology. Journal of Medical Colleges of PLA. 2012; 27(2): 101-12.
15.    Sarin SK, Kapur BM, Tandon RK. Cholesterol and pigment gallstones in Northern India. Digestive diseases and sciences. 1986; 31(10): 1041-5.
16.    Semnani V, Malek M, Khaniporshokooh S. Survey of the frequency of the types of gall stones and it's related risk factors in cholecystectomized patients in Semnan (2002-2003). koomesh Journal. 2004; 6(1): 15-2.
17.    Meves V, Pohl J. Trans-Abdominal Ultrasound Guided ERC in a Pregnant Woman with Bile Duct Stones. Video Journal and Encyclopedia of GI Endoscopy. 2014; 2(1): 9-11.
18.    Ibitoye BO, Adisa AO, Makinde ON, Ijarotimi AO. Prevalence and complications of gallstone disease among pregnant women in a Nigerian hospital. International Journal of Gynecology & Obstetrics. 2014; 125(1): 41-3.
19.    Date RS, Kaushal M, Ramesh A. A review of the management of gallstone disease and its complications in pregnancy. The American Journal of Surgery. 2008; 196(4): 599-608.
20.    Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. New England Journal of Medicine. 1978; 299(21): 1161-7.
21.    Cetta F, Lombardo F, Malet PF. Black pigment gallstones with cholesterol gallstones in the same gallbladder. Digestive diseases and sciences. 1995; 40(3): 534-8.
22.    Johnston DE, Kaplan MM. Pathogenesis and treatment of gallstones. New England Journal of Medicine. 1993; 328(6): 412-21.
23.    Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgraduate medical journal. 2001;77(906):221.
24.    Stinton LM, Myers RP, Shaffer EA. Epidemiology of Gallstones. Gastroenterology Clinics of North America. 2010; 39(2): 157-69.
25.    Andrews S. Gallstone size related to incidence of post cholecystectomy retained common bile duct stones. International Journal of Surgery. 2013; 11(4): 319-21.
26.    Gilat T, Feldman C, Halpern Z, Dan M, Bar-Meir S. An increased familial frequency of gallstones. Gastroenterology. 1983; 84(2): 242-6.
27.    Paracha PI, Asif Y, Vriesekoop F, Ullah S, Abbas M, Paracha SI, et al. Risk factors associated with gallstone disease in women. e-SPEN Journal. 2012; 7(3): e129-e34.
28.    Smelt AHM. Triglycerides and gallstone formation. Clinica Chimica Acta. 2010;411 (21-22): 1625-31.
29.    Afghani R, Aminian A, Mirsharifi SR, Jafarian A, Ghaderi H, Noaparast M, et al. Serum homocysteine level and gall stone disease: a case control study. Tehran University Medical Journal TUMS Publications. 2010; 68(8): 481-6.
30.    Knab LM, Boller A-M, Mahvi DM. Cholecystitis. Surgical Clinics of North America. 2014; 94(2):
455-70.
31.    Kaura SH, Haghighi M, Matza BW, Hajdu CH, Rosenkrantz AB. Comparison of CT and MRI findings in the differentiation of acute from chronic cholecystitis. Clinical Imaging. 2013; 37(4): 687-91.
32.    Chien W-H, Liu J-H, Hou W-Y, Shen H-J, Chang T-Y, Tung T-H. Clinical Implications in the

Incidence and Associated Risk Factors of Gallstone Disease Among Elderly Type 2 Diabetics in Kinmen, Taiwan. International Journal of Gerontology. 2014; 8(2): 95-9.
33.    Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A. The ABCG5/8 Cholesterol Transporter and Myocardial Infarction Versus Gallstone Disease. Journal of the American College of Cardiology. 2014; 63(20): 2121-8.